Advancium Health Network Catalyzes Research on an Innovative SARM1 Inhibitor in a Rare Eye Disease
NEW YORK, April 23, 2025 /PRNewswire/ -- Advancium Health Network, a public charity dedicated to advancing therapies for rare diseases, has awarded two major grants to accelerate research into a